Visit Reaction Biology at DYRK1A, related kinases and human diseases conference
5 - 9 October 2025 | Saint-Malo, France
Join us at the DYRK1A, related kinases and human diseases conference. At Reaction Biology, we provide comprehensive solutions to accelerate kinase-focused drug discovery. Our expertise spans biochemical and cell-based kinase assays, high-throughput screening, and custom assay development, enabling researchers to explore the therapeutic potential of DYRK and CLK kinases with precision and confidence.
Why Visit Us?
Kinase Profiling: Our diverse range of over 2,000 target-specific biochemical assays, including HotSpot™ - the industry leading kinase activity assay, DYRK1A, related kinases, and CLKs, for selectivity and potency assessment.
Custom Assay Development: Tailored solutions for unique targets and pathways.
Biophysical Screening: SPR, ITC, and thermal shift assays for binding kinetics and mechanism-of-action studies.
Cell-Based Assays: Validate compound activity in physiologically relevant systems.
Structural Biology Support: Insights into kinase structure and inhibitor interactions.
Whether you’re investigating neurodegenerative diseases, oncology, or other indications linked to DYRK and CLK kinases, Reaction Biology is your trusted partner for high-quality, data-driven discovery.
Connect with our experts at the DYRK1A Conference in Saint-Malo to discuss your research needs!
